Clinical Trials Logo
  1. Home
  2. Hypertension
  3. NCT01128933
  4. Details
NCT01128933 Clinical Trial

Renal Fractional Flow Reserve in Renal Artery Stenting

Hypertension Clinical Trial

— PREFFER  

Official title:
Prognostic Value of Renal Fractional Flow Reserve in Hypertensive Patients With Renal Artery Stenosis Qualified to Renal Artery Stenting

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01128933
Other study ID # 2P05B02530
Secondary ID
Status Completed
Phase N/A
First received May 21, 2010
Last updated May 21, 2010
Start date June 2006
Est. completion date May 2010

Study information
Verified date May 2010
Source Institute of Cardiology, Warsaw, Poland
Contact n/a
Is FDA regulated No
Health authority Poland: Ministry of Science and Higher Education
Study type Interventional

Clinical Trial Summary

The purpose of the study is to determine potential utility of renal fractional flow reserve in prognosis predicting after renal stent implantation.

Recruitment information / eligibility
Status Completed
Enrollment 45
Est. completion date May 2010
Est. primary completion date December 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- At least moderate (60% or more) renal artery stenosis with atheromatic appearance in angiography

- Hypertension defined according to WHO criteria

- Age 18-75 years

- Signed informed consent obtained

Exclusion Criteria:

- Bilateral renal artery stenosis or significant renal artery stenosis in solitary kidney

- Contraindications to percutaneous renal angioplasty with stenting

- Atrophy of the kidney supplied with stenosed artery

- Other well known secondary reason for hypertension

- Chronic heart failure NYHA II-IV

- Significant valvular heart disease qualified for surgery

- Persistent atrial fibrillation

- Renal failure with GFR below 30ml/min

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Procedure:
• Renal artery stenting

Locations
Country Name City State
Poland Institute of Cardiology Warsaw

Sponsors (2)
Lead Sponsor Collaborator
Institute of Cardiology, Warsaw, Poland Ministry of Science and Higher Education, Poland

Country where clinical trial is conducted

Poland, 

Outcome
Type Measure Description Time frame Safety issue
Primary Blood pressure improvement 6 months No
Secondary Kidney function preservation 6 months No
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A

External Links